NICM
CLMT icon

Neo Ivy Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Neo Ivy Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51,435
Closed -$1.85M – 382
2026
Q1 		$1.85M Buy
+51,435
New +$1.33M 0.49% 80

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Neo Ivy Capital Management's CLMT Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 51,435 shares — an estimated $1.85M sold.

Neo Ivy Capital Management first reported a position in CLMT in Q1 2026 and held it in 1 quarter. The position peaked at $1.85M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Neo Ivy Capital Management reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
  • Neo Ivy Capital Management sold 51,435 Calumet Specialty Products shares in Q2 2026, an estimated $1.85M.
  • Neo Ivy Capital Management first reported a position in Calumet Specialty Products in Q1 2026 and held it in 1 quarter.
  • Neo Ivy Capital Management's Calumet Specialty Products position peaked at $1.85M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.